KingMed’s parent company, KingMed Diagnostics, is a leading diagnostic company group in Southern china with 30 subsidiaries and provides services including medical diagnostics testing, clinical trial testing, medical research services and hygiene testing. The Guangzhou diagnostic lab covers 9 specialties including clinical chemistry, analytical chemistry, clinical hematology, clinical immunology, clinical microbiology, genetics, molecular pathology, cytopathology and histopathology. KingMed has a 12,500 s.f. Central laboratory in Kwun Tong providing routine clinical services. KingMed will establish a new 1,800 s.f. Lab at HKSP focusing on the development of next generation sequencing (NGS) protocols to facilitate the diagnosis of new infectious diseases based on molecular biology approaches that will have higher sensitivity and better accuracy than routine culture-based or multplex PCR methodologies. In phase two, mass-spectromety-based platform for the diagnosis of inborn errors of metabolism and hormonal disorders will be established.